DMAC · DiaMedica Therapeutics Inc. · Executive Compensation
$9.33
-0.33 (-3.42%)
At close · Nov 12
Return incl. dividend (before tax)
Earnings today
Play latest call
Q2 2026 earnings call transcript
Market Cap
$503.13M
Shares
53.93M
Volume · Nov 12
187.78K
Avg daily vol (3M)
194.88K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Rick Pauls | President and Chief Executive Officer | $2,727,350 |
| Julie Krop | M.D.^(d)^ Chief Medical Officer | $1,707,563 |
| Scott Kellen | Chief Financial Officer and Secretary | $1,229,520 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Rick Pauls | President and Chief Executive Officer | $1,550,985 |
| Lorianne Masuoka | Chief Medical Officer | $1,174,310 |
| Scott Kellen | Chief Financial Officer and Secretary | $813,955 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Rick Pauls | President and Chief Executive Officer | $1,215,161 |
| Scott Kellen | Chief Financial Officer and Secretary | $632,215 |
| Kirsten Gruis | Former Chief Medical Officer | $596,083 |
| Julie Daves | SVP, Clinical Development Operations | $533,370 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Rick Pauls | President and Chief Executive Officer | $1,080,607 |
| Kirsten Gruis | Former Chief Medical Officer | $1,004,691 |
| Scott Kellen | Chief Financial Officer and Secretary | $563,574 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Rick Pauls | President and Chief Executive Officer | $1,136,169 |
| Scott Kellen | Chief Financial Officer and Secretary | $546,720 |
| Harry Alcorn | Jr., Pharm.D.^^ Senior Vice President of Clinical Operations | $545,268 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Rick Pauls | President and Chief Executive Officer | $878,203 |
| Harry Alcorn | Jr., Pharm.D.^^ Senior Vice President of Clinical Operations | $509,065 |
| Scott Kellen | Chief Financial Officer and Secretary | $489,303 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Harry Alcorn | Jr., Pharm.D.^^ Chief Medical Officer | $778,300 |
| Rick Pauls | President and Chief Executive Officer | $733,707 |
| Scott Kellen | Chief Financial Officer and Secretary | $677,807 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Rick Pauls | President and Chief Executive Officer | $733,707 |
| Scott Kellen | Chief Financial Officer and Secretary | $642,921 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Julie Krop, M.D. | Chief Medical Officer | Appointed | 2025-08-06 |
| Lorianne Masuoka, M.D. | Chief Medical Officer | Resigned | 2025-08-06 |
| Richard Pilnik | member of the Board of Directors | Retired | 2025-03-06 |
| Daniel J. O'Connor | to the Board | Appointed | 2025-02-24 |
| Richard Kuntz, M.D., M.Sc. | Director | Appointed | 2024-05-23 |
| Rick Pauls | Director | Appointed | 2024-05-23 |
| Charles Semba, M.D. | Director | Appointed | 2024-05-23 |
| James Parsons | Director | Appointed | 2024-05-23 |
| Michael Giuffre, M.D. | Director | Appointed | 2024-05-23 |
| Tanya Lewis | Director | Appointed | 2024-05-23 |
| Richard Pilnik | Director | Appointed | 2024-05-23 |
| Julie VanOrsdel Daves MSHS, CCRP | Senior Vice President, Clinical Development Operations | Resigned | 2024-04-10 |
| Kirsten Gruis, M.D. | Chief Medical Officer | Resigned | 2023-09-05 |
| Richard E. Kuntz, M.D., M.Sc. | Board of Directors | Appointed | 2023-05-30 |
| Tanya N. Lewis | to the Board | Appointed | 2023-03-06 |
| Amy L. Burroughs | director | Resigned | 2023-03-06 |
Leadership
- Rick Pauls CEO, Board Member
- James Parsons Chairman
- Charles Semba Board Member
- Charles Semba, M.D. Board Member
- Daniel J. O'Connor Board Member
- Daniel O’Connor Board Member
- Michael Giuffre Board Member
- Michael Giuffre, M.D. Board Member
- Richard E. Kuntz, M.D., M.Sc. Board Member
- Richard Kuntz Board Member
- Richard Kuntz, M.D., M.Sc. Board Member
- Richard Pilnik Board Member
- Tanya Lewis Board Member
- Tanya N. Lewis Board Member
Key facts
CIK
1401040
CUSIP
25253X207
13F (30d)
47 filings
46 filers
Visit website
Investor relations